Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 11.
doi: 10.1007/s11764-024-01702-3. Online ahead of print.

Baseline predictors associated with successful weight loss among breast cancer survivors in the Lifestyle, Exercise, and Nutrition (LEAN) study

Rachel Hoobler  1   2 , Leah S Puklin  3 , Maura Harrigan  3 , Brenda Cartmel  3   4 , Fang-Yong Li  3 , Tara Sanft  4   5 , Leah M Ferrucci  3   4 , Melinda L Irwin  3   4   6 , Mary C Playdon  7   8
Affiliations

Baseline predictors associated with successful weight loss among breast cancer survivors in the Lifestyle, Exercise, and Nutrition (LEAN) study

Rachel Hoobler et al. J Cancer Surviv. .

Abstract

Purpose: To investigate participant characteristics associated with clinically meaningful weight loss (≥ 5% weight loss) among breast cancer survivors participating in the Lifestyle, Exercise, and Nutrition (LEAN) study.

Methods: Female breast cancer survivors with a body mass index ≥ 25 kg/m2 were enrolled in a 6-month weight loss intervention. Univariate and multivariable logistic regression were used to determine baseline predictors of clinically meaningful weight loss (< vs. ≥ 5%) among those in the intervention arm. The area under the receiver operator characteristic curve (ROC-AUC) C-statistic evaluated the final model's ability to classify weight loss success.

Results: Baseline data were available for 77 participants. Having a history of weight gain during breast cancer treatment was associated with lower odds of achieving ≥ 5% weight loss (OR = 0.36, 95% CI 0.13 - 0.99) compared to women with no history of weight gain during cancer treatment.

Conclusion: Breast cancer survivors with overweight or obesity who gained weight during their cancer treatment were less likely to achieve clinically meaningful weight loss during a post-treatment weight loss intervention.

Implication for cancer survivors: Breast cancer survivors are encouraged to achieve and maintain a healthy body weight to minimize the risk for cancer recurrence and comorbidity. Our results indicate that programs aimed at prevention of weight gain during treatment could aid in this goal. Understanding characteristics that increase or decrease the likelihood of achieving clinically meaningful weight loss will inform the design of programs that better support breast cancer survivors' weight loss success.

Keywords: Baseline predictors; Breast cancer; Lifestyle intervention; Weight loss.

PubMed Disclaimer

Conflict of interest statement

Declarations Ethics approval The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of Yale School of Medicine. Consent to participate Informed consent was obtained from all subjects involved in the study. Conflict of interest Financial Interests: Brenda Cartmel significant other Pfizer stock. Tara Sanft paid speaker for Hologic. Transparency statement LEAN1 (NCT02109068) and LEAN2 (NCT02110641) were both pre-registered at clinicaltrials.gov. The analysis plan was not formally pre-registered.

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492 . - DOI
    1. Wang Y, Beydoun MA, Min J, Xue H, Kaminsky LA, Cheskin LJ. Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic. Int J Epidemiol. 2020;49(3):810–23. https://doi.org/10.1093/ije/dyz273 . - DOI - PubMed - PMC
    1. Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288–98. https://doi.org/10.1038/s41574-019-0176-8 . - DOI - PubMed
    1. Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015;16(1):36–46. https://doi.org/10.1016/S1470-2045(14)71123-4 . - DOI - PubMed
    1. Runowicz CD, Leach CR, Henry NL, et al. American cancer society/american society of clinical oncology breast cancer survivorship care guideline. CA A Cancer J Clin. 2016;66(1):43–73. https://doi.org/10.3322/caac.21319 . - DOI

LinkOut - more resources